Search Results - Lund‐Johansen, Fridtjof
- Showing 1 - 20 results of 30
- Go to Next Page
-
1
-
2
-
3
Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response by Midtvedt, Karsten, Vaage, John Torgils, Heldal, Kristian, Munthe, Ludvig A., Lund-Johansen, Fridtjof, Åsberg, Anders
Published 2022Text -
4
Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes by Kumari, Shraddha, Wälchli, Sébastien, Fallang, Lars-Egil, Yang, Weiwen, Lund-Johansen, Fridtjof, Schumacher, Ton N., Olweus, Johanna
Published 2014Text -
5
-
6
Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination by König, Marton, Torgauten, Hilde Marie, Tran, The Trung, Holmøy, Trygve, Vaage, John Torgils, Lund-Johansen, Fridtjof, Nygaard, Gro Owren
Published 2022Text -
7
-
8
Prevalence of antibodies against SARS‐CoV‐2 in the Norwegian population, August 2021 by Tunheim, Gro, Rø, Gunnar Øyvind Isaksson, Chopra, Adity, Aase, Audun, Kran, Anne‐Marte Bakken, Vaage, John Torgils, Lund‐Johansen, Fridtjof, Hungnes, Olav
Published 2022Text -
9
Antibody engineering & therapeutics, the annual meeting of the antibody society December 7–10, 2015, San Diego, CA, USA by Pauthner, Matthias, Yeung, Jenny, Ullman, Chris, Bakker, Joost, Wurch, Thierry, Reichert, Janice M., Lund-Johansen, Fridtjof, Bradbury, Andrew R.M., Carter, Paul J., Melis, Joost P.M.
Published 2016Text -
10
Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic by Tunheim, Gro, Rø, Gunnar Øyvind Isaksson, Tran, Trung, Kran, Anne‐Marte Bakken, Andersen, Jan Terje, Vaage, Eline Benno, Kolderup, Anette, Vaage, John Torgils, Lund‐Johansen, Fridtjof, Hungnes, Olav
Published 2021Text -
11
Low Immunization Rate in Kidney Transplant Recipients Also After Dose 2 of the BNT162b2 Vaccine: Continue to Keep Your Guard up! by Midtvedt, Karsten, Tran, Trung, Parker, Krystina, Marti, Hans-Peter, Stenehjem, Aud-E., Gøransson, Lasse Gunnar, Mørkve Soldal, Kari, Madsen, Camilla, Smedbråten, Julia, Vaage, Eline Benno, Lund-Johansen, Fridtjof, Åsberg, Anders
Published 2021Text -
12
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination by Schultz, Nina H., Sørvoll, Ingvild H., Michelsen, Annika E., Munthe, Ludvig A., Lund-Johansen, Fridtjof, Ahlen, Maria T., Wiedmann, Markus, Aamodt, Anne-Hege, Skattør, Thor H., Tjønnfjord, Geir E., Holme, Pål A.
Published 2021Text -
13
Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study by Jorgensen, Kristin, Chopra, Adity, Sexton, Joseph, Tveter, Anne T, Hov, Johannes R., Jyssum, Ingrid, Nissen-Meyer, Lise Sofie H., Vaage, John T, Syversen, Silje W, Goll, Guro L, Lund-Johansen, Fridtjof, Jahnsen, Jørgen
Published 2022Text -
14
EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection by Lee, Yunsung, Riskedal, Espen, Kalleberg, Karl Trygve, Istre, Mette, Lind, Andreas, Lund-Johansen, Fridtjof, Reiakvam, Olaug, Søraas, Arne V. L., Harris, Jennifer R., Dahl, John Arne, Hadley, Cathrine L., Jugessur, Astanand
Published 2022Text -
15
Covid-19 transmission in fitness centers in Norway - a randomized trial by Helsingen, Lise M., Løberg, Magnus, Refsum, Erle, Gjøstein, Dagrun Kyte, Wieszczy, Paulina, Olsvik, Ørjan, Juul, Frederik E., Barua, Ishita, Jodal, Henriette C., Herfindal, Magnhild, Mori, Yuichi, Jore, Solveig, Lund-Johansen, Fridtjof, Fretheim, Atle, Bretthauer, Michael, Kalager, Mette
Published 2021Text -
16
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies by Akbar, Rahmad, Bashour, Habib, Rawat, Puneet, Robert, Philippe A., Smorodina, Eva, Cotet, Tudor-Stefan, Flem-Karlsen, Karine, Frank, Robert, Mehta, Brij Bhushan, Vu, Mai Ha, Zengin, Talip, Gutierrez-Marcos, Jose, Lund-Johansen, Fridtjof, Andersen, Jan Terje, Greiff, Victor
Published 2022Text -
17
The Antibody Society’s antibody validation webinar series by Voskuil, Jan L.A., Bandrowski, Anita, Begley, C. Glenn, Bradbury, Andrew R.M., Chalmers, Andrew D., Gomes, Aldrin V., Hardcastle, Travis, Lund-Johansen, Fridtjof, Plückthun, Andreas, Roncador, Giovanna, Solache, Alejandra, Taussig, Michael J., Trimmer, James S., Williams, Cecilia, Goodman, Simon L.
Published 2020Text -
18
Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults by Kared, Hassen, Wolf, Asia-Sophia, Alirezaylavasani, Amin, Ravussin, Anthony, Solum, Guri, Tran, Trung The, Lund-Johansen, Fridtjof, Vaage, John Torgils, Nissen-Meyer, Lise Sofie, Nygaard, Unni C., Hungnes, Olav, Robertson, Anna H., Næss, Lisbeth Meyer, Trogstad, Lill, Magnus, Per, Munthe, Ludvig A., Mjaaland, Siri
Published 2022Text -
19
Spatial-proteomics reveals phospho-signaling dynamics at subcellular resolution by Martinez-Val, Ana, Bekker-Jensen, Dorte B., Steigerwald, Sophia, Koenig, Claire, Østergaard, Ole, Mehta, Adi, Tran, Trung, Sikorski, Krzysztof, Torres-Vega, Estefanía, Kwasniewicz, Ewa, Brynjólfsdóttir, Sólveig Hlín, Frankel, Lisa B., Kjøbsted, Rasmus, Krogh, Nicolai, Lundby, Alicia, Bekker-Jensen, Simon, Lund-Johansen, Fridtjof, Olsen, Jesper V.
Published 2021Text -
20
In silico proof of principle of machine learning-based antibody design at unconstrained scale by Akbar, Rahmad, Robert, Philippe A., Weber, Cédric R., Widrich, Michael, Frank, Robert, Pavlović, Milena, Scheffer, Lonneke, Chernigovskaya, Maria, Snapkov, Igor, Slabodkin, Andrei, Mehta, Brij Bhushan, Miho, Enkelejda, Lund-Johansen, Fridtjof, Andersen, Jan Terje, Hochreiter, Sepp, Hobæk Haff, Ingrid, Klambauer, Günter, Sandve, Geir Kjetil, Greiff, Victor
Published 2022Text